Research Analysts Offer Predictions for CLB Q2 Earnings

Core Laboratories Inc. (NYSE:CLB) – Research analysts at Zacks Research reduced their Q2 2025 earnings per share estimates for shares of Core Laboratories in a report released on Wednesday, March 26th. Zacks Research analyst T. Saha now anticipates that the oil and gas company will post earnings per share of $0.21 for the quarter, down from their prior forecast of $0.25. The consensus estimate for Core Laboratories’ current full-year earnings is $0.96 per share. Zacks Research also issued estimates for Core Laboratories’ Q1 2026 earnings at $0.18 EPS, Q4 2026 earnings at $0.34 EPS and FY2027 earnings at $1.28 EPS.

Separately, Citigroup upgraded shares of Core Laboratories from a “sell” rating to a “neutral” rating and lifted their price target for the stock from $15.00 to $16.00 in a research note on Wednesday, March 12th. One equities research analyst has rated the stock with a sell rating and four have assigned a hold rating to the company. Based on data from MarketBeat.com, Core Laboratories currently has an average rating of “Hold” and a consensus target price of $17.50.

Core Laboratories Stock Performance

Shares of NYSE CLB opened at $15.30 on Friday. Core Laboratories has a 12-month low of $12.95 and a 12-month high of $25.13. The firm has a market capitalization of $716.45 million, a price-to-earnings ratio of 23.18, a price-to-earnings-growth ratio of 0.99 and a beta of 2.38. The company has a current ratio of 2.32, a quick ratio of 1.71 and a debt-to-equity ratio of 0.49. The firm has a 50 day moving average of $16.44 and a 200 day moving average of $18.09.

Core Laboratories (NYSE:CLB) last released its quarterly earnings results on Wednesday, January 29th. The oil and gas company reported $0.23 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.23. Core Laboratories had a return on equity of 16.24% and a net margin of 5.99%.

Core Laboratories Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, March 3rd. Shareholders of record on Monday, February 10th were paid a dividend of $0.01 per share. This represents a $0.04 dividend on an annualized basis and a yield of 0.26%. The ex-dividend date of this dividend was Monday, February 10th. Core Laboratories’s payout ratio is 6.06%.

Hedge Funds Weigh In On Core Laboratories

Several large investors have recently added to or reduced their stakes in the company. Disciplined Growth Investors Inc. MN raised its position in shares of Core Laboratories by 26.7% during the 3rd quarter. Disciplined Growth Investors Inc. MN now owns 5,653,591 shares of the oil and gas company’s stock valued at $104,761,000 after purchasing an additional 1,192,871 shares during the period. Raymond James Financial Inc. bought a new stake in Core Laboratories during the fourth quarter valued at about $6,760,000. Fisher Asset Management LLC lifted its position in shares of Core Laboratories by 19.5% in the third quarter. Fisher Asset Management LLC now owns 990,267 shares of the oil and gas company’s stock valued at $18,350,000 after acquiring an additional 161,278 shares in the last quarter. Rice Hall James & Associates LLC bought a new position in shares of Core Laboratories in the fourth quarter worth about $1,960,000. Finally, Norges Bank purchased a new stake in shares of Core Laboratories during the fourth quarter worth about $1,910,000. Hedge funds and other institutional investors own 97.81% of the company’s stock.

About Core Laboratories

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.